BB

Brian Bray

Professional Summary



Professional Overview


Brian Bray is an accomplished pharmaceutical executive with extensive expertise in Chemistry, Manufacturing, and Controls (CMC). As the Vice President of CMC at Parion Sciences, he leverages his deep industry knowledge and strategic leadership to drive innovative solutions and ensure the successful development and commercialization of pharmaceutical products.

Experience Summary



Current Role


As the Vice President of CMC at Parion Sciences, Brian is responsible for overseeing all aspects of the company's chemistry, manufacturing, and controls operations. He plays a pivotal role in guiding the organization's CMC strategy, ensuring regulatory compliance, and optimizing production processes to enhance efficiency and quality. Under his leadership, Parion Sciences has achieved significant milestones in the advancement of its pharmaceutical pipeline, contributing to the company's growth and industry recognition.

Career Progression


With over 15 years of experience in the pharmaceutical industry, Brian has a proven track record of success in various leadership roles. Prior to his current position, he served as the Director of CMC at Xellia Pharmaceuticals, where he spearheaded the implementation of innovative manufacturing technologies and streamlined operations to improve production capacity and cost-effectiveness. Earlier in his career, Brian held technical and supervisory roles at several leading pharmaceutical companies, further honing his expertise in CMC and process development.

Academic Background


Brian holds a Bachelor of Science degree in Chemical Engineering from the University of North Carolina at Chapel Hill, where he graduated with honors. He has also completed specialized training in Good Manufacturing Practices (GMP) and regulatory compliance, ensuring his expertise aligns with industry best practices.

Areas of Expertise


  • Chemistry, Manufacturing, and Controls (CMC) strategy and implementation

  • Pharmaceutical process development and optimization

  • Regulatory compliance and quality assurance

  • Project management and cross-functional collaboration

  • Technical leadership and team development


Professional Impact


Throughout his career, Brian has made significant contributions to the pharmaceutical industry. He has led the successful implementation of multiple CMC initiatives, resulting in enhanced production efficiency, improved product quality, and accelerated time-to-market for his organization's pipeline. Additionally, Brian has actively participated in industry forums and conferences, sharing his expertise and contributing to the advancement of CMC best practices.

Conclusion


With his extensive experience, strong technical acumen, and visionary leadership, Brian Bray is poised to continue driving Parion Sciences' CMC operations to new levels of excellence. His unwavering commitment to quality, innovation, and strategic problem-solving makes him a valuable asset to the organization and a respected leader in the pharmaceutical industry.